CXCL13 and PD-1+ CD8 T cells play key roles in the formation of tertiary lymphoid structures, which have been identified in several cancers and are typically associated with favorable outcomes (Sautès-Fridman et al., 2019; Workel et al., 2019). This evidence concerns the gene PDCD1 and cancer.